CClinicalTrials.gg
CompletedNCT00627770Updated Jan 29, 2009

Lower Leg Edema Evaluation After Total Knee Arthroplasty Using Bioimpedance

An interventional study of bioimpedance spectroscopy ImpediMed SFB7 Brisbane Australia in Edema, sponsored by Haute Ecole de Santé Vaud. Completed at 1 site in Switzerland. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2009-01-29.

Sponsored by Haute Ecole de Santé Vaud · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Not applicable
Ages
16 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate the applicability and measurement properties of bioimpedance spectroscopy for postsurgical edema assessment after total knee arthroplasty

Read the detailed description

Current measurement techniques of edema are not adapted or not convenient for assessment in the post surgical environment. Developement of a convenient, quick and reliable method could be useful to facilitate edema evaluation in this context.

02

Conditions studied

  • Edema

Browse trials for

Keywords

  • Physical Therapy - Therapeutics - Edema
  • Arthroplasty replacement knee
  • Treatment outcome
03

In context

Edema

825 studies on the registry are indexed under Edema; 91 are open to participants now.

This study's enrollment of 34 is below the median of 52 across 601 interventional studies indexed under Edema.

Browse Edema studies →

Lead sponsor

Haute Ecole de Santé Vaud is the lead sponsor of 17 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • knee replacement surgery

Exclusion criteria

Exclusion Criteria:

  • pacemaker
  • cardiac defibrillator
  • other metallic implant than knee arthroplasty
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
34 participants (actual)

Interventions

  • Devicebioimpedance spectroscopy ImpediMed SFB7 Brisbane Australia

    edema evaluation using bioimpedance

06

What researchers measure

Primary outcomes

  1. bioimpedance ratio right/left

    Time frame: presurgery, 2 and 8 days post surgery

07

Study locations

1 site
  • Département de l'Appareil Locomoteur - CHUV
    Lausanne, 1005, Switzerland
08

References and documents

Publications

  • Pichonnaz C, Bassin JP, Lecureux E, Currat D, Jolles BM. Bioimpedance spectroscopy for swelling evaluation following total knee arthroplasty: a validation study. BMC Musculoskelet Disord. 2015 Apr 25;16:100. doi: 10.1186/s12891-015-0559-5. PubMed 25907994 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00627770
Lead sponsor
Haute Ecole de Santé Vaud
Collaborators
University of Applied Sciences of Western Switzerland, University of Lausanne Hospitals
First posted
Mar 3, 2008
Start date
Jan 2008
Primary completion
Nov 2008
Completion
Nov 2008
Last update
Jan 29, 2009

Study contacts

Claude A Pichonnaz, physiother.
principal investigator · Haute Ecole de Santé Vaud
Brigitte M Jolles, PhD MER MSc
study director · Département de l'Appareil Locomoteur - CHUV + Faculté des sciences et techniques de l'ingénieur (STI) - EPFL
Correvon Marc, Engineer
principal investigator · Haute Ecole Vaudoise d'Ingénierie et de Gestion

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion